Clinical Trial

ORI MONITORING IN LOW AND NORMAL FLOW ANESTHESIA APPLICATIONS

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 20, 2026 (before its estimated July 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
Oxygen administration is essential in the perioperative period to prevent hypoxia; however, excessive oxygen may cause hyperoxia and related complications. While pulse oximetry is effective in detecting hypoxemia, it is insufficient for identifying hyperoxia when SpO₂ exceeds 97%, often necessitating invasive arterial blood gas analysis. The Oxygen Reserve Index (ORI) is a noninvasive, real-time monitoring parameter reflecting moderate hyperoxic ranges (PaO₂ 100-200 mmHg) and provides early warning of oxygenation changes before SpO₂ alterations occur. Combined use of ORI and pulse oximetry may enable optimal oxygen titration and prevention of both hypoxemia and hyperoxemia. Laparoscopic nephrectomy is widely performed due to its clinical advantages. In our practice, low and normal fresh gas flow anesthesia are commonly used. Low-flow anesthesia offers benefits such as preservation of heat and humidity, reduced cost, and improved airway physiology. This study aims to determine optimal oxygenation levels during laparoscopic nephrectomy under low and normal fresh gas flow conditions using ORI monitoring.
Trial Details
NCT Number NCT07538817
Lead Sponsor Başakşehir Çam & Sakura City Hospital
Conditions HYPEROXY, OXYGEN RESERVE INDEX
Enrollment 48 participants
Start Date 2026-04-20
Primary Completion 2026-07-20 (estimated)
Study Completion 2026-08-20 (estimated)
Updated on ClinicalTrials.gov 2026-04-20